Institutional Ownership Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS). We have compiled data on the 84 institutions that hold shares in the stock, with a total of 50.7 Million shares, which have been reported (via 13F filing form) to have a value of $138 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
292,845
shares
|
$846,322
0.0% of portfolio
|
Q3 2024
Reduced 68.87%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 15, 2024 Q3 2024 |
264,377
shares
|
$764,049
0.02% of portfolio
|
Q1 2023
Reduced 8.89%
|
|
|
Gsa Capital Partners LLP
London, X0 |
Nov 05, 2024 Q3 2024 |
255,032
shares
|
$737,042
0.02% of portfolio
|
Q3 2024
Reduced 24.25%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Nov 14, 2024 Q3 2024 |
199,119
shares
|
$575,453
0.01% of portfolio
|
Q3 2024
Added 32.13%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
188,721
shares
|
$545,403
0.0% of portfolio
|
Q3 2024
Reduced 4.02%
|
|
|
Assenagon Asset Management S.A.
|
Oct 23, 2024 Q3 2024 |
185,777
shares
|
$536,895
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Squarepoint Ops LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
140,580
shares
|
$406,276
0.0% of portfolio
|
Q3 2024
Added 48.47%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
139,400
shares
|
$402,866
0.0% of portfolio
|
Q2 2024
Added 27.0%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
127,225
shares
|
$367,680
0.0% of portfolio
|
Q3 2024
Reduced 75.56%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
Nov 14, 2024 Q3 2024 |
90,000
shares
|
$260,100
0.02% of portfolio
|
Q3 2024
New holding
|
|
|
Marquette Asset Management, LLC
|
Oct 08, 2024 Q3 2024 |
83,979
shares
|
$242,699
0.01% of portfolio
|
Q1 2024
New holding
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
82,727
shares
|
$239,081
0.0% of portfolio
|
Q3 2024
Reduced 75.31%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
76,810
shares
|
$221,980
0.0% of portfolio
|
Q3 2024
Added 0.07%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
62,408
shares
|
$180,359
0.0% of portfolio
|
Q3 2024
Reduced 69.79%
|
|
|
Bbr Partners, LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
60,000
shares
|
$173,400
0.01% of portfolio
|
Q1 2024
New holding
|
|
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
Nov 14, 2024 Q3 2024 |
52,052
shares
|
$150,430
0.01% of portfolio
|
Q3 2024
Reduced 51.77%
|
|
|
Mariner, LLC
Overland Park, KS |
Nov 13, 2024 Q3 2024 |
48,101
shares
|
$139,011
0.0% of portfolio
|
Q3 2024
Added 13.99%
|
|
|
Cambridge Investment Research Advisors, Inc.
|
Oct 28, 2024 Q3 2024 |
41,873
shares
|
$121,012
0.0% of portfolio
|
Q4 2023
Added 173.0%
|
|
|
Engineers Gate Manager LP
New York, NY |
Nov 14, 2024 Q3 2024 |
38,794
shares
|
$112,114
0.0% of portfolio
|
Q3 2024
Reduced 35.92%
|
|
|
Paul Tudor Jones
Tudor Investment Corp Et Al | Stamford, Ct
|
Nov 14, 2024 Q3 2024 |
33,183
shares
|
$95,898
0.0% of portfolio
|
Q3 2023
Added 0.0%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
31,852
shares
|
$92,052
0.0% of portfolio
|
Q3 2024
Reduced 5.74%
|
|
|
Virginia Retirement Systems Et Al
Richmond, VA |
Jan 02, 2024 Q3 2023 |
27,200
shares
|
$78,608
0.0% of portfolio
|
Q3 2023
New holding
|
|
|
Shay Capital LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
27,000
shares
|
$78,030
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2024 Q3 2024 |
21,909
shares
|
$63,317
0.0% of portfolio
|
Q3 2024
Added 9.18%
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
20,393
shares
|
$58,935
0.0% of portfolio
|
Q3 2024
Reduced 49.33%
|